Pacific Biosciences: Meyer reports 44,000 shares

Available on EDGAR 11/13/2026 - 04:09 PM EST Accepted by SEC EDGAR 11/13/2026 - 04:08 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Pacific Biosciences of California, Inc. (PACB) reports Chief Accounting Officer William Meyer with 44,000 shares of common stock, each represented by a restricted stock unit (RSU). The RSUs vest in equal annual installments on September 15 of 2027, 2028, 2029 and 2030, subject to his continued status as a service provider through each applicable date.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider MEYER WILLIAM

Role See Remarks

Type	Security	Shares	Price	Value
Holding	Common Stock F1	--	--	--

Holdings: Common Stock — 44,000 shares (Direct)

Footnotes (1)

1. F1. Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on September 15 of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Key Figures

Common stock represented by RSUs: 44,000 shares

1 metrics

Common stock represented by RSUs 44,000 shares Reported for Chief Accounting Officer William Meyer; direct holding

Key Terms

Restricted Stock Unit ("RSU")

1 terms

Restricted Stock Unit ("RSU") financial

"Each share is represented by a Restricted Stock Unit ("RSU")."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PACB shares does William Meyer hold?

William Meyer is reported with 44,000 shares of common stock, each represented by a restricted stock unit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

MEYER WILLIAM

(Last) (First) (Middle)

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

1305 O'BRIEN DRIVE

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
11/03/2026

3. Issuer Name and Ticker or Trading Symbol
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. [ PACB ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	44,000(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on September 15 of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Remarks:

Chief Accounting Officer, Exhibit List: Exhibit 24 - Power Of Attorney

	/s/ Brett Atkins, Attorney-in-fact	11/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)